Antifolate agent aminopterin demonstrates potent anti-monkeypox virus activity in vitro and in vivo
Microbiology Spectrum · 04.08.2026 · 14 (8)
DOI: 10.1128/spectrum.01581-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Jing Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Eye Research Institute (EYE-X Institute), Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Antiviral Agents, Aminopterin, Folic Acid Antagonists, Monkeypox virus. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The ongoing spread of the monkeypox outbreak underscores the urgent need for the development of effective therapeutics against the monkeypox virus (MPXV). Aminopterin is a classical antifolate agent known for its anti-tumor activity through the inhibition of folate metabolism. Here, aminopterin was identified as an effective anti-MPXV agent. It significantly inhibited MPXV replication, unlike other antifolate agents such as methotrexate, pemetrexed, and LSN3213218. In Vero E6 cells, the half-maximal inhibitory concentration (IC₅₀) was 36.10 nM, the half-cytotoxic concentration (CC₅₀) was 3,310 nM, and the selectivity index (SI) was 91.690. In human foreskin fibroblast cells, the IC 50 was 32.73 nM, CC₅₀ exceeded 10 μM, and SI was greater than 305.530. In vivo , aminopterin not only inhibited MPXV infection but also mitigated high-dose viral infection-associated inflammation. Furthermore, the data indicated that aminopterin reduced viral load by interfering with viral attachment and replication. Together, these findings identify aminopterin as a promising candidate for anti-MPXV drug development. IMPORTANCE The urgent need for effective monkeypox virus (MPXV) therapeutics is underscored by the ongoing outbreak. This study identifies aminopterin as a potent anti‑MPXV agent among four antifolate agents. Crucially, aminopterin suppresses viral infection and mitigates infection-associated inflammation in vivo . These findings position aminopterin as a potential candidate for the development of an antiviral agent against MPXV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Eye Research Institute (EYE-X Institute), Bengbu Medical University, Bengbu, China.
- Key Laboratory of Infection and Immunity of Anhui Higher Education Institutes, Bengbu Medical University, Bengbu, China.
- School of Public Health, Fujian Medical University, Fuzhou, China.
- Institute for Hepatology, National Clinical Research Center for Infectious Diseases , Shenzhen Third People's Hospital, Shenzhen, China.
- Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Jing Wu, Deyan Chen
Zitieren
APA
Wu, J., Duan, M., Cheng, L., & Chen, D. (2026). Antifolate agent aminopterin demonstrates potent anti-monkeypox virus activity in vitro and in vivo. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.01581-25
Vancouver
Wu J, Duan M, Cheng L, Chen D. Antifolate agent aminopterin demonstrates potent anti-monkeypox virus activity in vitro and in vivo. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.01581-25
BibTeX
@article{Wu2026,
author = {Wu, Jing and Duan, Meimei and Cheng, Lin and Chen, Deyan},
title = {Antifolate agent aminopterin demonstrates potent anti-monkeypox virus activity in vitro and in vivo},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {8},
doi = {10.1128/spectrum.01581-25}
}
EUVIMED